Mangrove Partners Im, LLC
About Mangrove Partners Im, LLC’s 13F portfolio
Mangrove Partners Im, LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Mangrove Partners Im, LLC reported $1.5B across 426 US-listed positions (). Its largest position is INDIVIOR PHARMACEUTICALS INC (INDV) at 7.2% of the reported book, and its ten biggest holdings make up 38% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NASDAQ: INDV INDIVIOR PHARMACEUTICALS INC | $26.74 −5.21% | 7.2% | 2.7M | $109.8M |
| 2 | NASDAQ: VISN VISTANCE NETWORKS INC | — — | 6.0% | 7.2M | $91.5M |
| 3 | NYSE: ATMU ATMUS FILTRATION TECHNOLOGIE | $53.23 −0.82% | 4.1% | 1.2M | $61.8M |
| 4 | NASDAQ: FLYW FLYWIRE CORPORATION | $21.40 −1.65% | 3.4% | 3.0M | $52.4M |
| 5 | NASDAQ: TIGO MILLICOM INTL CELLULAR S A | $78.35 −5.13% | 3.3% | 556K | $50.5M |
| 6 | NYSE: REX REX AMERICAN RES CORP | $34.76 −1.81% | 3.0% | 1.0M | $45.8M |
| 7 | NASDAQ: KDP KEURIG DR PEPPER INC | $34.41 −1.71% | 2.9% | 1.4M | $44.7M |
| 8 | NYSE: MRP MILLROSE PPTYS INC | $24.84 −0.92% | 2.7% | 1.4M | $41.5M |
| 9 | NASDAQ: ACHC ACADIA HEALTHCARE COMPANY IN | $34.47 −8.30% | 2.7% | 1.4M | $41.2M |
| 10 | NYSE: PCG PG&E CORP | $13.94 +1.68% | 2.7% | 2.4M | $40.6M |
| 11 | NYSE: UNP UNION PAC CORP | $290.63 −3.41% | 2.6% | 148K | $40.3M |
| 12 | NYSE: OKE ONEOK INC NEW | $86.52 −1.37% | 2.6% | 462K | $40.1M |
| 13 | NYSE: CODI COMPASS DIVERSIFIED | $12.21 −3.25% | 2.6% | 3.7M | $39.3M |
| 14 | NYSE: APTV APTIV PLC | $37.36 −3.16% | 2.5% | 613K | $37.7M |
| 15 | NYSE: GPC GENUINE PARTS CO | $121.54 −1.70% | 2.5% | 317K | $37.4M |
| 16 | NYSE: BIO BIO RAD LABS INC | $367.50 −0.72% | 2.5% | 127K | $37.3M |
| 17 | NASDAQ: OTEX OPEN TEXT CORP | $22.32 −2.83% | 2.4% | 1.6M | $36.3M |
| 18 | NYSE Arca: ETH GRAYSCALE ETHEREUM STAKING | $16.77 +0.48% | 2.2% | 2.2M | $33.6M |
| 19 | NASDAQ: BELFA BEL FUSE INC | $173.03 −0.96% | 2.0% | 105K | $30.5M |
| 20 | NYSE: BILL BILL HOLDINGS INC | $64.08 −2.92% | 2.0% | 839K | $30.3M |
| 21 | NASDAQ: NWSA NEWS CORP NEW | $25.31 −3.14% | 1.9% | 1.2M | $29.6M |
| 22 | NYSE Arca: IWM ISHARES TR | $264.22 −2.18% | 1.8% | 92K | $27.7M |
| 23 | NYSE: FIS FIDELITY NATL INFORMATION SV | $25.94 −2.96% | 1.7% | 658K | $25.6M |
| 24 | NYSE: AIV APARTMENT INVT & MGMT CO | $1.44 +2.86% | 0.9% | 4.5M | $13.2M |
| 25 | — DISCIPLINED GROWTH | — — | 0.5% | 750K | $7.5M |
Showing 1–25 of 426 positions on this page reported in this 13F.
- Healthcare14%
- Technology13%
- Financial Services10%
- Consumer Cyclical10%
- Industrials6.9%
- Communication Services5.5%
- Real Estate4.2%
- Basic Materials3.6%
- Utilities3.4%
- Consumer Defensive3.2%
- Energy3.1%
- AddedVISNVISTANCE NETWORKS INC+59843%$91.5M
- NewACHCACADIA HEALTHCARE COMPANY IN—$41.2M
- NewAPTVAPTIV PLC—$37.7M
- AddedBIOBIO RAD LABS INC+0.3%$37.3M
- AddedOTEXOPEN TEXT CORP+64.9%$36.3M
- AddedBELFABEL FUSE INC+8106%$30.5M
- NewIWMISHARES TR—$27.7M
- NewAIVAPARTMENT INVT & MGMT CO—$13.2M
- New—DISCIPLINED GROWTH—$7.5M
- NewQLEPQUANTUM LEAP ACQUISITION COR—$7.4M
- ReducedINDVINDIVIOR PHARMACEUTICALS INC−2.4%$109.8M
- ReducedATMUATMUS FILTRATION TECHNOLOGIE−7.9%$61.8M
- ReducedFLYWFLYWIRE CORPORATION−1.0%$52.4M
- ReducedETHGRAYSCALE ETHEREUM STAKING−37.2%$33.6M
- ReducedAXINAXIOM INTELLIGENCE AC CORP 1−49.0%$4.7M
- ReducedNWENORTHWESTERN ENERGY GROUP IN−17.7%$1.6M
- ReducedAVTRAVANTOR INC−1.0%$1.4M
- ReducedVMDVIEMED HEALTHCARE INC−8.1%$868K
- ReducedAHCOADAPTHEALTH CORP−55.6%$763K
- ReducedANIPANI PHARMACEUTICALS INC−29.1%$758K
Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.
| # | Stock | Type | % of class | Shares | Filed |
|---|---|---|---|---|---|
| 1 | CTAA ClearThink 1 Acquisition Corp. | 13G | 8.4% | 1.1M | Filed 20 JUL 2026 |
| 2 | ANEB Anebulo Pharmaceuticals, Inc. | 13G | 6.2% | 2.5M | Filed 17 MAR 2025 |
| 3 | CHPG ChampionsGate Acquisition Corp | 13G | 5.7% | 492K | Filed 14 NOV 2025 |
Showing all 3 disclosed stakes. 1 last disclosed over a year ago (the holder may since have dropped below 5%).
Reading Mangrove Partners Im, LLC’s 13F portfolio
Mangrove Partners Im, LLC’s $1.5B 13F book is spread across 426 reported positions and is moderately diversified, the ten largest names accounting for 38%. There are meaningful positions at the top alongside a long tail of smaller holdings. Its five largest positions are INDV, VISN, ATMU, FLYW and TIGO, led by INDIVIOR PHARMACEUTICALS INC (INDV) at 7.2% of the portfolio. The heaviest sector exposure is Healthcare (14%), then Technology (13%).
What Mangrove Partners Im, LLC changed last quarter
Between 2026-03-31 and Q2 2026, Mangrove Partners Im, LLC was roughly balanced between buying and selling: it opened 199 new positions and added to 41 more, while trimming 61 and closing 200 outright. Against a 426-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was VISTANCE NETWORKS INC (VISN), and its biggest reduction was INDIVIOR PHARMACEUTICALS INC (INDV).
What a 13F does and doesn’t reveal
A 13F captures only Mangrove Partners Im, LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Mangrove Partners Im, LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Mangrove Partners Im, LLC's profile on this page is built directly from those filings.
How current is the 13F data on Mangrove Partners Im, LLC's page?
It reflects Mangrove Partners Im, LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Mangrove Partners Im, LLC files its next quarterly report, this page refreshes automatically.
Can I see Mangrove Partners Im, LLC's complete list of holdings?
This page highlights Mangrove Partners Im, LLC's largest positions rather than all 426 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Mangrove Partners Im, LLC's filings.
Does a 13F show everything Mangrove Partners Im, LLC owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Mangrove Partners Im, LLC's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Mangrove Partners Im, LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

